- Home
- PRQR vs CFBK Comparison
PRQR vs CFBK Comparison
Compare PRQR & CFBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRQR
- CFBK
- Stock Information
- Founded
- PRQR 2012
- CFBK 1892
- Country
- PRQR Netherlands
- CFBK United States
- Employees
- PRQR N/A
- CFBK N/A
- Industry
- PRQR Biotechnology: Pharmaceutical Preparations
- CFBK Major Banks
- Sector
- PRQR Health Care
- CFBK Finance
- Exchange
- PRQR Nasdaq
- CFBK Nasdaq
- Market Cap
- PRQR 179.1M
- CFBK 154.9M
- IPO Year
- PRQR 2014
- CFBK 1998
- Fundamental
- Price
- PRQR $2.13
- CFBK $24.15
- Analyst Decision
- PRQR Strong Buy
- CFBK Buy
- Analyst Count
- PRQR 8
- CFBK 1
- Target Price
- PRQR $8.88
- CFBK $29.00
- AVG Volume (30 Days)
- PRQR 362.3K
- CFBK 36.4K
- Earning Date
- PRQR 08-07-2025
- CFBK 08-05-2025
- Dividend Yield
- PRQR N/A
- CFBK 1.16%
- EPS Growth
- PRQR N/A
- CFBK N/A
- EPS
- PRQR N/A
- CFBK 2.28
- Revenue
- PRQR $21,212,711.00
- CFBK $47,663,000.00
- Revenue This Year
- PRQR N/A
- CFBK $35.39
- Revenue Next Year
- PRQR N/A
- CFBK $10.11
- P/E Ratio
- PRQR N/A
- CFBK $10.58
- Revenue Growth
- PRQR 85.91
- CFBK 1.22
- 52 Week Low
- PRQR $1.07
- CFBK $18.33
- 52 Week High
- PRQR $4.62
- CFBK $31.17
- Technical
- Relative Strength Index (RSI)
- PRQR 64.73
- CFBK 64.99
- Support Level
- PRQR $1.89
- CFBK $23.30
- Resistance Level
- PRQR $2.54
- CFBK $24.39
- Average True Range (ATR)
- PRQR 0.14
- CFBK 0.39
- MACD
- PRQR 0.01
- CFBK 0.04
- Stochastic Oscillator
- PRQR 43.06
- CFBK 78.76
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.
About CFBK CF Bankshares Inc.
CF Bankshares Inc is engaged in the provision of a variety of financial services. It provides personalized business banking products and services, including commercial loans and leases, commercial and residential real estate loans, equipment leasing, SBA loans and treasury management depository services. The revenues are derived principally from the interest and fees on loans originated and noninterest income generated on the sale of loans.